Login to Your Account

Arrow Raises £21M In First Closing Of Second Round

By Nuala Moran

Wednesday, October 8, 2003
LONDON - Arrow Therapeutics Ltd. raised more than £21 million in the first close of its second-round funding, which should enable it to advance two antiviral products into clinical trials next year and complete preclinical development of antibacterial leads. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription